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Introduction
Although IFN-γ plays a central role in controlling the
host’s response to bacterial and viral infection, the pre-
cise cellular mechanisms that contribute to this obligate
role in host defense have not been fully elucidated (1).
These IFN-γ–dependent events depend exclusively on
signal transducer and activator of transcription factor
1 (STAT1) activation, since mice lacking this signal
transducer are defective in their ability to resolve bacte-
rial and viral infections (2–4). That IFN-γ is important
in regulating host defense is emphasized by evidence of
its effect on leukocyte recruitment. In this respect, IFN-γ
can both enhance and suppress chemokine secretion in
response to proinflammatory cytokines (IL-1β and
TNF-α), modulate chemokine receptor expression, and
affect cellular adhesion and transmigration (5–10). In
vivo, however, it is unclear whether these actions on
leukocyte trafficking are a direct result of IFN-γ or occur
through its modulation of other mediator cascades dur-
ing the inflammatory response. Recent data, however,
suggest that the initial activation of resident CD4 T cells
to produce IFN-γ (and IL-17) are important in directing
neutrophil (PMN) recruitment and in resolving bacter-
ial infection (11–13).
During acute inflammation, PMN trafficking is
tightly regulated to provide effective host defense
without promoting tissue injury. Initially, PMN are
recruited from the circulation toward sites of inflam-
matory insult or infection in response to local secre-
tion of neutrophil-activating chemokines containing
the ELR amino acid motif (ELR+) (14). As inflamma-
tion proceeds, or infection subsides, PMN are removed
in a controlled manner to prevent persistent tissue
necrosis (15). The initial phase of PMN clearance
results from the downregulation of local ELR+ CXC
chemokine expression and a switch to other chemo-
kines selective for the attraction of mononuclear cells
(MNC) (16). Central to the removal of PMN is the
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process of programmed cell death (apoptosis), which
renders the cells susceptible to nonphlogistic phago-
cytosis by the MNC infiltrate. The controlled process
of PMN trafficking thus provides an effective mech-
anism for limiting inflammation-induced tissue
damage. Ultimately, this leads to clearance of infec-
tion and resolution of inflammation (13, 15, 17).
Consequently, the pattern of PMN infiltration
encountered during an inflammatory episode is
defined by the temporal and differential regulation
of chemokines and PMN apoptosis.
To define the regulatory events that dictate the
pattern of leukocyte trafficking encountered during
inflammation, we have used an established murine
model of acute peritoneal inflammation using either
a cell-free supernatant derived from Staphylococcus
epidermidis or IL-1β as a stimulus (8, 16). This model
has allowed the examination of the temporal
changes in leukocyte infiltration and inflammatory
and chemotactic mediator expression. Changes in
this model closely resemble those observed in
human bacterial peritonitis characterized by tempo-
ral changes in the expression patterns of both proin-
flammatory and chemotactic cytokines, the rapid
recruitment of PMN, and their subsequent replace-
ment by a more sustained influx of MNC (16).
Although the factors that orchestrate resolution of
acute inflammation and restoration of normal tis-
sue architecture are not fully defined, we have recent-
ly characterized important roles for both IL-6,
through its soluble IL-6 receptor (sIL-6R), and IFN-γ
signaling in regulating the transition between PMN
and MNC infiltration (8, 16). In the present study,
we extend these observations and have identified
that IFN-γ dictates the pattern of PMN recruitment
encountered by affecting the local activities of IL-1β
and IL-6. In this way, IFN-γ is able to tightly control
the initial recruitment of PMN and promote their
subsequent clearance to ensure effective host defense
and resolution of inflammation.
Methods
Reagents. All chemicals were purchased from Sigma-
Aldrich (St. Louis, Missouri, USA) unless otherwise
stated. Recombinant human IL-1β, TNF-α, IFN-γ
(107 U/mg of protein), and soluble gp130 (sgp130)
were from R&D Systems (Abingdon, United King-
dom). Recombinant murine IL-1β and IFN-γ were
from Peprotech Ltd. (London, United Kingdom).
Endotoxin levels in recombinant cytokines were less
than 0.1ng/µg (1 EU/µg) of protein. Tissue culture
reagents were from GibcoBRL/Life Technologies
(Paisley, United Kingdom), and all culture flasks and
multiwell plates were obtained from Falcon (BD Bio-
sciences, Oxford, United Kingdom). PBS (pH 7.4)
was obtained from GibcoBRL/Life Technologies.
HYPER-IL-6 was prepared as previously described
(18) and stored at –70°C. A fresh aliquot was used
for each experiment.
Isolation and culture of human peritoneal mesothelial cells.
Human peritoneal mesothelial cells (HPMC) were iso-
lated by tryptic digestion of greater omental tissue
obtained from consenting patients undergoing
abdominal surgery and characterized as previously
described (19). All experiments were performed with
confluent HPMC from the second passage. Cells were
washed and growth arrested for 48 hours in serum-
free culture medium before cytokine stimulation.
Growth- arrested HPMC were stimulated at 37°C
under the conditions specified in the figure legends.
Culture supernatants were harvested, centrifuged to
remove cellular debris, and stored at –70°C until
assayed by ELISA. All data for in vitro cytokine pro-
duction is expressed in picograms per 105 HPMC.
Northern blot analysis. Total cellular RNA was extract-
ed from HPMC using RNA Isolator (Genosys Biotech-
nologies Ltd., Poole, United Kingdom). Ten micro-
grams of total cellular RNA was fractionated in a
formaldehyde/1% agarose gel. RNA was transferred
overnight to nylon membrane (Boehringer-Mann-
heim, Lewis, United Kingdom) by capillary action and
fixed by UV irradiation. Membranes were preincubat-
ed in hybridization solution (5× SSC, 0.1% N-lauroyl-
sarcosine, 0.02% [vol/vol] SDS, 1% [wt/vol] Boeh-
ringer-Mannheim blocking reagent) for 1 hour at
42°C. Blots were hybridized overnight at 42°C with a
digoxigenin (DIG) -labeled oligonucleotide probe (10
ng/ml) for human IL-6 (R&D Systems). Membranes
were washed and nonspecific binding sites blocked by
incubating the membrane for 30 minutes in 1%
(wt/vol) blocking reagent. Labeled transcripts were
detected using an alkaline phosphatase–conjugated
anti-DIG antibody (1:10,000 dilution; Boehringer-
Mannheim) and visualized by autoradiography us-
ing the chemiluminescent substrate CSPD (Boeh-
ringer-Mannheim). Membranes were stripped in
boiling 0.1% (wt/vol) SDS (twice for 30 minutes each)
and reprobed with a DIG-labeled oligonucleotide for
β-actin (10 ng/ml, R & D Systems). Blots were devel-
oped as described above. Autoradiographs were
quantified by densitometry and expressed as a ratio
of the housekeeping gene β-actin.
Analysis of nuclear extracts. Nuclear extracts were pre-
pared from HPMC using a rapid technique for the
extraction of DNA binding proteins. Briefly, cells were
harvested in ice-cold PBS (pH 7.4) and pelleted by cen-
trifugation. Cells were resuspended in ice-cold buffer
A (10 mm HEPES-KOH [pH 7.9], 1.5 mM MgCl2, 10
mM KCl, 0.5 mM DTT, 0.2 mM PMSF) and incubated
on ice for 10 minutes. The cell pellet was collected by
centrifugation, resuspended in buffer B (20 mM
HEPES-KOH [pH 7.9], 25% glycerol, 420 mM NaCl, 1.5
mM MgCl2, 0.2 mM EDTA, 0.3 mM DTT, 0.2 mM
PMSF), and incubated on ice for 20 minutes to allow
for high salt extraction. Cellular debris was removed by
brief high-speed centrifugation (1200 g for 10 seconds
at 4°C), and the resulting supernatants (nuclear
extract) were collected. Protein concentrations were
The Journal of Clinical Investigation | August 2003 | Volume 112 | Number 4 599
600 The Journal of Clinical Investigation | August 2003 | Volume 112 | Number 4
determined using the Bradford method. Electro-
phoretic mobility shift assays (EMSA) were performed
as previously described (20). Oligonucleotides con-
taining consensus motifs for NF-κB (5′-gaTCCATGG-
GGAATTCCCC-3′ and 3′-AGGTACCCCTTAAGGGGag-5′)
were annealed for use in EMSA. These double-strand-
ed fragments were labeled with [α32P]dTTP (Amer-
sham-Pharmacia Biotech, Amersham, United King-
dom) using the Klenow fragment of DNA polymerase
I. The composition of protein/DNA complexes was
determined by supershift assays using rabbit poly-
clonal antibodies specific for NF-κB–p50 (sc-7178)
and NF-κB–p65 (sc-109) (Santa Cruz Biotech Inc.,
Santa Cruz, California, USA).
Mouse strains. All experimental procedures were carried
out under Home Office project license 40/2131. Inbred
wild-type C57/BL6 mice were purchased from Charles
River UK Ltd (Margate, United Kingdom). IL-6–
deficient (IL-6–/–) and IFN-γ–deficient (IFN-γ–/–) mice,
both on the C57/BL6 background, were bred in house
from breeding pairs originally purchased from the Jack-
son Laboratory (Bar Harbor, Maine, USA) (21, 22). All
mice were maintained under barrier conditions and
were pathogen free as assessed by regular microbiologi-
cal screening. Mice were between 6 and 12 weeks of age
and were weight matched for each experiment.
Preparation of S. epidermidis cell-free supernatant and defi-
nition of biological activity. S. epidermidis cell-free super-
natant (SES) was prepared as previously described (16,
23). Supernatants were free of live bacteria, as assessed
by lack of growth on diagnostic sensitivity testing agar.
Lyophilized stocks of SES were stored at –70°C. The
biological activity of SES was determined by monitor-
ing IL-6 secretion from RAW 264 mouse macrophages
(European Collection of Cell Cultures, Salisbury, Wilt-
shire, United Kingdom). RAW 264 cells were main-
tained in 10% FCS/DMEM F12 MIX supplemented
with 100 U/ml penicillin, 100 U/ml streptomycin, 2
mM L-glutamine, and a 1:100 dilution of nonessential
amino acids at 37°C/5% CO2 in a humidified atmos-
phere. For bioassay, RAW 264 cells were adhered to 24-
well plates at a density of 7.5 × 104 cells per well and stim-
ulated with serial dilutions of lyophilized SES. After 24
hours, supernatants were collected and IL-6 was quan-
tified. For experimental reproducibility, SES fractions
(equivalent to 5 × 104 CFU/ml) were only used when 
IL-6 secretion by RAW 264 exceeded 300 pg per 104 cells.
Induction of acute peritoneal inflammation. Peritoneal
inflammation was induced in vivo by administration
of SES or recombinant murine IL-1β. Groups of wild-
type, IFN-γ–/–, and IL-6–/– mice received 500 µl of SES,
IL-1β, or PBS through the intraperitoneal route. At
defined time points, animals were sacrificed, and their
peritoneum was lavaged with 2 ml of ice-cold PBS.
The composition of the leukocyte infiltrate was
assessed using a Coulter counter (Coulter Z2, Beck-
man-Coulter UK Ltd., High Wycombe, United King-
dom) and by differential cell staining. Lavage fluids
were rendered cell free by centrifugation for analysis
of inflammatory mediators. To modulate the inflam-
matory response, wild-type, IFN-γ–/–, or IL-6–/– mice were
treated intraperitoneally with 500 µl of SES, IL-1β,
(100 ng per mouse), IFN-γ (0.05–50 U per mouse),
HYPER-IL-6 (40 ng per mouse), and sgp130 (150 ng
per mouse) as indicated in the figure legends. PBS was
used as a control. At intervals after administration,
mice were sacrificed and lavage parameters assessed.
Cytokine and chemokine production. Murine IL-6, KC,
and IL-1β levels were quantified using commercially
available ELISA kits (R&D Systems). Human IL-6 was
quantified using matched antibody pairs from R&D
Systems in an ELISA (24).
Assessment of apoptosis in vivo (annexin V/propidium
iodide staining). At defined intervals after SES stimula-
tion, mice were sacrificed and the peritoneal cavity
lavaged. Total leukocytes were recovered, and apopto-
sis was determined by double staining with annexin V
and propidium iodide (PI) according to the protocol
instructions (R&D Systems). The proportion of apop-
totic leukocytes was assessed using a Becton-Dickin-
son FACSCalibur flow cytometer (Becton-Dickinson,
Oxford, United Kingdom) using defined forward- and
side-scatter settings for mouse leukocytes. Analysis of
annexin V staining was performed on gated neu-
trophils, and the quadrants were aligned in accor-
dance with autofluorescent controls. Ten thousand
gated events were acquired for each sample.
Assessment of apoptosis in vivo (caspase 3 activity). After
SES stimulation, mice were sacrificed and total leuko-
cytes recovered from the peritoneal cavity by lavage.
Caspase 3 activity was assessed in cell pellets after lysis
according to the manufacturer’s instructions
(Apoalert, BD-Clontech UK, Basingstoke, United
Kingdom). Briefly, caspase 3 activity was assessed by
cleavage of p-nitroaniline (pNA) from a caspase-spe-
cific substrate DEVD-pNA at 37°C for 60 minutes
and expressed as nanomoles of pNA per 106 leuko-
cytes. To confirm specificity of the observed changes,
an inhibitor of caspase 3 activity (DEVD-fmk) was
added to parallel samples of activated leukocytes iso-
lated from wild-type mice injected with SES.
To modulate sIL-6R signaling in these experiments,
mice were intraperitoneally administered with SES in
combination with HYPER-IL-6 (40 ng per mouse) or
sgp130 (150 ng per mouse), as indicated in the figure
legends, before assessment of apoptosis.
Statistical comparisons. Data are expressed as means ±
SEM, and statistical analysis was performed using a
Student’s unpaired t test (Statview SE+Graphics [Ver-
sion 1.03] software). A P value of less than 0.05 was
considered statistically significant.
Results
IFN-γ deficiency disrupts PMN infiltration during peritoneal
inflammation. We have previously observed that IFN-γ
differentially controls ELR+ CXC and CC chemokine
expression by HPMC (8). To establish the overall
effect of IFN-γ on leukocyte recruitment, peritoneal
inflammation was induced in wild-type and IFN-γ–/–
mice by administration of SES (16). In wild-type
mice, this resulted in a time-dependent influx of
PMN into the peritoneal cavity, which peaked at 3
hours (Figure 1a). In the absence of IFN-γ, fewer infil-
trating PMN were detected (Figure 1a). Indeed, the
rate of PMN recruitment in IFN-γ–/– mice was
impaired, and PMN numbers remained elevated for
up to 12 hours after induction of inflammation (Fig-
ure 1a). Consistent with these observations, aberrant
PMN recruitment in IFN-γ–/– mice was also accompa-
nied by a defect in KC production (Figure 1b). Thus,
IFN-γ might affect both the initial PMN recruitment
phase and their subsequent clearance.
IFN-γ regulates the initial rate of PMN infiltration. Recon-
stitution of IFN-γ signaling in IFN-γ–/– mice facilitat-
ed a dose-dependent increase in the initial rate of
PMN infiltration (Figure 1c), with 50 U of IFN-γ per
mouse restoring the profile of intraperitoneal KC
secretion to that observed in wild-type mice (Figure
1b). However, it is evident that other inflammatory
processes must also affect PMN infiltration, since
maximal PMN recruitment was not encountered until
approximately 6 hours after reconstitution with 50 U
of IFN-γ per mouse (Figure 1a).
IFN-γ deficiency is associated with a defect in IL-1β and
IL-6 production. Administration of SES induced an
early increase in intraperitoneal IL-1β production
that peaked at 1 hour in wild-type mice (Figure 2a).
However, this profile of IL-1β was altered in IFN-γ–/–
mice and resulted in both reduced levels and a delay
in the peak of IL-1β production (Figure 2a). Thus, the
effect of IFN-γ on PMN recruitment may occur as a
consequence of this impaired expression of IL-1β. We
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Figure 1
IFN-γ deficiency modulates the PMN infiltration in SES-induced peritoneal inflammation. (a) Wild-type and IFN-γ–/– mice were intraperi-
toneally administered with PBS, SES, or SES in combination with IFN-γ (50 U per mouse). At defined time points, PMN infiltration was
assessed using differential cell counting (*P < 0.05, a significant increase versus IFN-γ–/– plus SES; #P < 0.05, a significant decrease versus
IFN-γ–/– plus SES). (b) KC levels were quantified by ELISA (*P < 0.05, a significant increase versus IFN-γ–/– plus SES). Results are expressed
as the mean ± SEM of 10 mice per treatment. (c) The rate of PMN infiltration in response to exogenous administration of IFN-γ (0.5–500
U per mouse) to IFN-γ–/– mice. Filled circles represent IFN-γ–/– mice receiving SES in combination with defined doses of IFN-γ. The open cir-
cle illustrates the rate of PMN infiltration in wild-type mice.
Figure 2
IL-1β and IL-6 production after SES-induced peri-
toneal inflammation in wild-type and IFN-γ–/–
mice. (a) Wild-type or IFN-γ–/– mice were intra-
peritoneally administered with PBS or SES. At
specific time intervals, mice were sacrificed,
and intraperitoneal IL-1β levels were quanti-
fied using ELISA (*P < 0.05 versus PBS). (b)
Wild-type or IFN-γ–/– mice were intraperi-
toneally administered with PBS, SES, IFN-γ
(0.5 U per mouse), or a combination of SES
and IFN-γ. Intraperitoneal IL-6 levels were
quantified at defined time intervals (*P < 0.05
versus IFN-γ–/– plus SES alone). The lower pan-
els show wild-type and IFN-γ–/– mice treated
with PBS alone. Values represent the mean ±
SEM (n = 6 mice per condition).
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have established that IL-6, in combination with sIL-6R,
regulates the transition between PMN and MNC
infiltration in a similar manner to that elicited by
IFN-γ (8, 16). To determine whether intraperitoneal
IL-6 levels are influenced by IFN-γ, inflammation was
provoked in both wild-type and IFN-γ–/– mice with
SES. Administration of SES to wild-type mice result-
ed in a time-dependent increase in IL-6 generation,
which peaked at 1 hour (Figure 2b). However, the
profile of IL-6 production in IFN-γ–/– mice was sig-
nificantly attenuated (threefold lower at 1 hour) but
was almost completely restored to wild type by reple-
tion with IFN-γ (Figure 2b), suggesting that IFN-γ
locally regulates intraperitoneal IL-6 levels.
IFN-γ regulates the secretion of IL-6 by mesothelial cells.
We have previously demonstrated that mesothelial
cells are the major producers of IL-6 within the peri-
toneal cavity (24, 25), and its production plays a
central role in regulating leukocyte recruitment
(16). Exposure of HPMC to IL-1β resulted in a time-
and dose-dependent increase in IL-6 production,
which was synergistically enhanced by the simulta-
neous presence of IFN-γ (Figure 3a). Synergistic
augmentation of the IL-1β response by IFN-γ was
confirmed at the transcriptional level by Northern
blot analysis (Figure 3b).
To establish if the synergistic effects of IFN-γ on 
IL-1β–driven IL-6 production occurs at the level of
their signal transduction pathways, activation of the
Jak-STAT and NF-κB pathways was monitored by
EMSA. STAT1 activation was maximal after 30 min-
utes of stimulation with IFN-γ alone and was unaf-
fected by the presence of IL-1β (data not shown). In
contrast, activation of NF-κB by IL-1β alone was max-
imal after 15 minutes (Figure 3c), with the intensity
of the banding declining thereafter. However, in com-
bination with IFN-γ, the IL-1β–induced activation of
NF-κB was maintained over the whole time course
Figure 3
Regulation of IL-6 production by IL-1β and IFN-γ in vitro and in vivo. Growth-arrested HPMC were (a) incubated with medium alone or
IL-1β (100 pg/ml) in the presence or absence of IFN-γ (100 U/ml). At specific time points, IL-6 levels were quantified using ELISA (*P < 0.05,
a significant increase versus the additive value of IL-1β plus IFN-γ alone). (b) Northern blot analysis of total RNA isolated from HPMC incu-
bated for 3 hours with medium and IL-1β (100 pg/ml) in the presence or absence of IFN-γ (100 U/ml). Representative results for three sep-
arate experiments are shown. (c) HPMC were stimulated with medium alone (lane 1), HYPER-IL-6 (500 pg/ml, lane 2), IFN-γ (100 U/ml,
lane 3), IL-1β (100 pg/ml, lane 4), or a combination of IL-1β and IFN-γ (lane 5). At the indicated intervals, nuclear extracts were prepared
and NF-κB activation was monitored by EMSA. (d) Composition of the NF-κB complex was determined by supershift using antibodies against
p50 (lane 2) and p65 (lane 3). No antibodies were included in lane 1. Results are representative of three separate experiments performed
with HPMC from different donors. (e) Wild-type mice were intraperitoneally administered with PBS, IL-1β (100 ng per mouse), IFN-γ (0.5 U
per mouse), or a combination of IL-1β and IFN-γ at these doses. After 1 hour, mice were sacrificed and IL-6 was quantified (*P < 0.05 ver-
sus PBS alone; **P < 0.05, a significant increase versus the additive value of IL-1β plus IFN-γ alone).
studied (Figure 3c). Supershift analysis identified that
the NF-κB complex resulted from activation of the
p50 and p65 NF-κB subunits (Figure 3d).
IFN-γ regulates intraperitoneal IL-6 production in vivo. To
confirm the observations presented in Figure 3 (a and b),
IL-6 production by IFN-γwas monitored in vivo. Inflam-
mation was induced in wild-type mice using IL-1β as an
inflammatory stimulus (Figure 3e). Although adminis-
tration of IFN-γ alone had no significant effect on
intraperitoneal IL-6 secretion, coadministration with
IL-1β (100 ng per mouse) resulted in a synergistic
increase in intraperitoneal IL-6 levels (Figure 3e).
IFN-γ controls PMN recruitment in wild-type but not in
IL-6–/– mice. In previous studies, we have demonstrat-
ed the ability of IFN-γ to downregulate IL-1β–induced
ELR+ CXC chemokine production and PMN recruit-
ment into the peritoneal cavity of wild-type mice (8). To
investigate if IFN-γ downregulates PMN recruitment
through an effect on IL-6 signaling, we examined the
ability of IFN-γ to control PMN recruitment in wild-
type and IL-6–/– mice. In wild-type mice, IL-1β–induced
PMN recruitment and KC production were both sig-
nificantly reduced after IFN-γ treatment (Figure 4, a
and c). However, intraperitoneal administration of
IFN-γ to IL-6–/– mice did not alter PMN recruitment
or KC production (Figure 4, b and d).
IL-6 signaling restores the control of PMN trafficking in
IFN-γ deficiency. Data in IL-6–/– mice indicated that the
ability of IFN-γ to control PMN recruitment is cou-
pled to the in vivo expression of IL-6. To confirm this
dependency on IL-6, inflammation was induced in
IFN-γ–/– mice with either SES or IL-1β. To reconstitute
IL-6 signaling, mice were administered with an engi-
neered IL-6/sIL-6R fusion protein (HYPER-IL-6) (18)
in combination with the activators of inflammation
(SES or IL-1β). HYPER-IL-6 has previously been
shown to suppress PMN infiltration (16) and, as pre-
dicted, significantly suppressed KC production and
PMN recruitment in IFN-γ–/– mice in response to
either SES- or IL-1β–induced activation (Figure 5).
IFN-γmodulates PMN apoptosis through regulation of IL-6
activity. By a comparison of the profile of PMN infil-
tration in wild-type and IFN-γ–/– mice, it appears that
IFN-γ directly influences the initial phase of recruit-
ment of PMN and also indirectly acts to control their
subsequent clearance (Figure 1a). Using annexin V/PI
staining activity as a marker of apoptosis, we observed
that PMN apoptosis after SES activation was defec-
tive in the absence of IFN-γ and remained impaired
throughout the duration of the clearance phase
(Table 1). Indeed, by comparing the profiles of the
annexin V/PI scatter plots, it is evident that the pro-
portion of both early (lower right quadrant) and late
apoptotic/necrotic (upper right quadrant) PMN was
significantly impaired in both IFN-γ–/– and IL-6–/– mice
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Figure 4
Regulation of PMN clearance by IFN-γ is dependent on IL-6 activity.
Wild-type (a and c) and IL-6–/– (b and d) mice were intraperitoneal-
ly administered with PBS, IL-1β (100 ng per mouse), IFN-γ (0.5 U
per mouse), or IFN-γ in combination with IL-1β at these doses. PMN
infiltration was assessed at 3 hours using differential cell counting
(a and b), and intraperitoneal KC levels were quantified at 1 hour by
ELISA (c and d). Results are expressed as the mean ± SEM (n = 5
mice per condition; *P < 0.05 versus PBS; **P < 0.05, a significant
decrease versus IL-1β alone).
Figure 5
Reconstitution of IL-6/sIL-6R signaling in IFN-γ–/– mice normalizes
the control of PMN clearance. IFN-γ–/– mice were intraperitoneal-
ly administered with PBS, SES, IL-1β (100 pg/ml), HYPER-IL-6 (40
ng per mouse, H-IL-6), or combinations of SES with HYPER-IL-6
or IL-1β with HYPER-IL-6. PMN infiltration was assessed at 3 hours
through differential cell counting (a and c), and intraperitoneal KC
levels were quantified at 1 hour (b and d). Results are expressed as
the mean ± SEM (n = 5 mice per condition; *P < 0.05 versus PBS;
**P < 0.05, a significant decrease versus SES or IL-1β alone).
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(Figure 6). Defective PMN apoptosis in IFN-γ–/– and
IL-6–/– mice was also confirmed by measurement of
leukocyte caspase 3 activity after induction of SES-
induced inflammation. As shown in Figure 7b, cas-
pase 3 activity was significantly reduced in both IFN-γ–/–
and IL-6–/– mice as compared with wild-type mice.
To establish a potential link between IFN-γ and
IL-6 in controlling PMN apoptosis, IL-6/sIL-6R sig-
naling was modulated in wild-type and IFN-γ–/– mice
(Figure 7, a and b). Blockade of sIL-6R signaling in
wild-type mice using sgp130 (26) significantly
reduced the proportion of early apoptosis as
assessed by annexin V staining (lower right quad-
rant) but had no apparent effect on late apoptot-
ic/necrotic PMN (Figure 7a). Under identical condi-
tions, however, administration of sgp130 to wild-
type mice significantly reduced caspase 3 activation,
confirming that there was indeed a defect in apop-
tosis under conditions of IL-6/sIL-6R signaling defi-
ciency (Figure 7b). Conversely, administration of
HYPER-IL-6 to IFN-γ–/– mice restored leukocyte
apoptosis to levels comparable with
those seen in wild-type mice (Figure
7b). Thus, IFN-γ modulates PMN
apoptosis through an effect on sIL-6R–
induced signaling within the peri-
toneal cavity. Consistent with the
notion that sIL-6R signaling is piv-
otal in the controlled removal of
neutrophils during acute inflamma-
tion is the observation that IL-6–/–
mice demonstrate aberrant clearance
of PMN from the peritoneal cavity
after SES-induced inflammation
(Figure 7c) and that inhibition of
sIL-6R signaling in wild-type mice,
with sgp130, results in a profile of
PMN recruitment consistent with
that seen in IL-6–/– mice (Figure 7c).
These IL-6/sIL-6R–driven effects
appear to be related to the control of
neutrophil clearance, since the initial
rate of PMN influx remained unaf-
fected by sgp130 blockade.
Discussion
IFN-γ plays a central role in govern-
ing immune cell responses and T cell
polarization. However, it is becom-
ing increasingly apparent that this
cytokine also orchestrates innate
immune responses (2, 4). Although
data suggest that these effects are
related to induction of genes associ-
ated with innate cellular immunity,
the precise mechanisms by which
this cytokine contributes to host
defense and the resolution of
inflammation remain to be fully
identified (1). To ensure that the
inflammatory response provides an efficient mecha-
nism for eradicating bacterial infection without dam-
aging host tissues, leukocyte recruitment, activation,
and clearance is tightly regulated (17). Previously, we
have established that IFN-γ can modulate chemokine
production and leukocyte recruitment in response to
proinflammatory cytokines (8). Coordination of these
processes is highly reminiscent of the inflammatory
events controlled by IL-6 and its soluble receptor,
sIL-6R (16). In light of the congruence between the
activities of IFN-γ and IL-6, we have now explored the
potential interplay between these inflammatory
cytokines in regulating leukocyte trafficking.
Initial experiments examined the effect of IFN-γ defi-
ciency on the process of PMN recruitment. Induction
of inflammation in IFN-γ–/– mice with SES resulted in
modulation of the PMN recruitment profile, defined
by a delay in the rate of initial accumulation, aberrant
clearance, and a reduction in overall PMN numbers.
Repletion experiments (with murine IFN-γ) resulted in
partial restoration of recruitment of PMN, with the
Table 1
Profile of intraperitoneal apoptosis in wild-type and IFN-γ–/– mice
Apoptotic leukocytes (%)
Time Wild-type mice IFN-γ–/– mice
(hours)
LR UR LR UR
6 14.2 ± 1.75 13.2 ± 4.4 8.50 ± 1.20A 5.9 ± 0.9A
9 13.1 ± 0.40 9.4 ± 0.4 9.79 ± 1.50A 6.9 ± 1.26A
12 17.2 ± 1.75 9.26 ± 0.7 13.19 ± 1.98A 8.2 ± 0.3A
Apoptotic leukocytes elicited from SES-stimulated mice were monitored by FACS analysis using
annexin V/PI dual labeling. Data are taken from the lower right (LR) and upper right (UR) quad-
rants to represent the proportion of early apoptotic and late apoptotic/necrotic leukocytes. Values
represent the mean ± SEM (n = 4–6 mice per condition, AP < 0.05 versus respective quadrant value).
Figure 6
IFN-γ and IL-6 modulate leukocyte apoptosis during SES-induced peritoneal inflam-
mation. Annexin V/PI staining of leukocytes isolated from the peritoneal cavity of wild-
type, IFN-γ–/–, and IL-6–/– mice. Representative scatter plots show FACS analysis of
gated PMN obtained from mice stimulated with SES for 6 hours. Apoptotic cells were
identified according to annexin V+/PI– (lower right quadrant, early apoptosis) and
annexin V+/PI+ (upper right quadrant, late apoptosis/necrosis) staining. The propor-
tion of cells residing in each quadrant is expressed as a percentage (mean ± SEM,
n = 4–7 mice/condition; *P < 0.05, a significant increase versus IFN-γ–/– plus SES). By
comparison with values from wild-type mice, mean reductions of 40.2% and 55.4%
were respectively seen in early and late apoptotic events for IFN-γ–/– mice and of 66.2%
and 48.9% for IL-6–/– mice. The proportion of annexin V+/PI– PMN in mouse periph-
eral blood was always less than 1% (data not shown).
most striking effect being in controlling the initial rate
of their recruitment into the peritoneal cavity. IFN-γ
thus appears to directly influence the effector arm of
PMN recruitment as a result of its ability to regulate
the local concentrations of ELR+ chemokines (KC/
macrophage inflammatory peptide–2). This response
to IFN-γ would seem to be independent of IL-6, since
the initial rate of PMN infiltration is unaffected by
IL-6 or blockade of sIL-6R signaling with sgp130, and
IL-6 deficiency is associated with greater PMN infil-
tration, increased KC/macrophage inflammatory
peptide–2 expression, and a delay in neutrophil clear-
ance (Figure 7c) (16, 27).
The mechanism by which IFN-γ controls initial PMN
recruitment is at least in part related to the early secre-
tion of IL-1β in response to SES, since its production is
reduced after induction of inflammation in IFN-γ–/–
mice. Consequently, combined IFN-γ and IL-1β signal-
ing appear to play a pivotal role in controlling the ini-
tial rate of PMN recruitment through their regulation
of ELR+ CXC chemokine expression. In this respect, we
have previously observed that IFN-γ dose-dependently
modulates IL-1β– or TNF-α–driven CXCL8 (IL-8) pro-
duction (8). In the context of the peritoneal cavity, the
mesothelium performs a major role in host defense
against bacterial infection, and as in other organ sys-
tems, local chemokine secretion plays a pivotal role in
controlling these processes (28, 29). Such concentra-
tion-dependent effects of IFN-γ are relevant to bacteri-
al peritonitis, in which temporal changes in intraperi-
toneal IL-1, TNF-α, and IFN-γ levels are observed
during the progression of inflammation (12).
We have previously identified that both IFN-γ and
IL-6 signaling through sIL-6R contribute to the
process of PMN removal from the peritoneal cavity
and a shift from innate to acquired immunity (16).
The data presented herein emphasize that a deficien-
cy in IFN-γ is accompanied by a defect in IL-6 expres-
sion and PMN removal from the peritoneal cavity.
Reconstitution of IFN-γ signaling in IFN-γ–/– mice
restored IL-6 secretion and identifies a direct role for
IFN-γ in controlling local IL-6 generation. Indeed, by
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Figure 7
Modulation of IL-6 signaling in vivo affects apoptotic clearance of PMN in SES-induced peritoneal inflammation. (a) Annexin V/PI stain-
ing of leukocytes. Representative scatter plots show similar analysis performed on cells elicited from wild-type mice after 6 hours of stim-
ulation with SES in combination with sgp130 (150 ng per mouse) or IFN-γ–/– mice after stimulation with SES in combination with HYPER-
IL-6 (40 ng per mouse). (b) Caspase 3 activity was evaluated in isolated leukocytes from wild-type, IFN-γ–/–, and IL-6–/– mice
intraperitoneally administered with SES, IFN-γ–/– mice administered with SES in combination with HYPER-IL-6 (40 ng per mouse), or wild-
type mice administered with SES in combination with sgp130 (150 ng per mouse). Data (expressed as nanomoles of pNA per 106 cells)
is presented from the 6-hour time point (mean ± SEM, n = 5 mice per condition; *P < 0.05, a significant decrease versus wild type plus
SES; **P < 0.05, a significant decrease versus IFN-γ–/– plus SES). Inclusion of the caspase 3 inhibitor DEVD-fmk to wild-type leukocyte
extracts reduced activity to background levels (data not shown). (c) Wild-type mice were intraperitoneally administered SES, SES plus
sgp130 (150 ng per mouse), or PBS, and IL-6–/– mice were intraperitoneally administered SES or PBS. At defined intervals, PMN infiltra-
tion was assessed by differential cell count. The lower panel shows PMN influx in response to PBS alone. Results are expressed as the
mean ± SEM of 12 mice per treatment (*P < 0.05 versus wild-type mice).
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modulating the activities of IL-6 (through its soluble
receptor) and IFN-γ in IL-6- and IFN-γ–deficient mice,
we have clearly shown that IFN-γ promotes the clear-
ance of PMN by regulating local IL-6 levels. In vitro
studies emphasize that IFN-γ and IL-1β synergistical-
ly induce the expression of IL-6, paralleling studies in
human monocytes (30). This interplay of IL-1β and
IFN-γ signaling appears to result in the maintenance
of NF-κB activity (Figure 3c) (31, 32).
The apparent defect in PMN clearance in IFN-γ–/–
mice challenged with SES led us to examine the mech-
anisms controlling the apoptosis of senescent PMN.
Using both annexin V/PI staining and caspase 3 acti-
vation to characterize both early and late apoptotic
events (33), we identified significantly reduced levels
of apoptosis in both IFN-γ and IL-6 deficiency. Recon-
stitution of IL-6/sIL-6R signaling in IFN-γ–/– and IL-6–/–
mice restored apoptosis, which emphasizes that IL-6
signaling through its soluble receptor promotes PMN
apoptosis. This conclusion is directly supported by
the studies presented using sgp130 as the natural
sIL-6R antagonist (26). Administration of sgp130 to
wild-type mice significantly blocked the in vivo acti-
vation of caspase 3 and reduced the proportion of
PMN entering early apoptosis. Although in these
experiments no significant difference was observed in
the proportion of late apoptotic/necrotic PMN, as
assessed by annexin V+/PI+ cells, this is perhaps not
surprising given that sgp130 augments PMN recruit-
ment and residence time, while concomitantly block-
ing MNC infiltration (Figure 7c) (16). Such a dispro-
portionate skewing of the leukocyte influx may
ultimately impinge on the nonphlogistic removal of
PMN by infiltrating MNC and result in a higher pro-
portion of late apoptotic and necrotic cells being
retained at the inflammatory focus. Although the pre-
cise cellular mechanisms governing these effects on
apoptosis are yet to be defined, previous studies have
identified that IFN-γ can modulate apoptotic path-
ways through cathepsin D– or Fas-related pathways
(34–36), whereas IL-6 can rescue T cells from apopto-
sis through induction of bcl-2 and bcl-xl (37). Indeed,
both IL-6 and STAT1/3 signaling have been implicat-
ed in protection against Fas-mediated cell death
through modulating cell-surface Fas and antiapop-
totic gene expression in T lymphocytes (38–40).
These observations on the role of sIL-6R in promot-
ing PMN apoptosis during acute inflammation con-
trast with its ability to promote lymphocyte survival in
chronic inflammatory conditions such as Crohn’s dis-
ease (41). Interestingly, under these conditions elevat-
ed IL-6 levels are paralleled by increases in IFN-γ, sug-
gestive of potential interactions between these signaling
pathways in controlling T cell apoptosis (39, 41), an
observation recently substantiated in a model of T
cell–mediated experimental hepatitis in IFN-γ–/– and
IL-6–/– mice (42). The ability of IL-6 (and IFN-γ) sig-
naling to balance pro- and antiapoptotic events in dis-
tinct leukocyte populations may be crucial to the
transition between innate and acquired immunity.
Indeed, such differential regulation of pro- and anti-
apoptotic signals may promote the nonphlogistic
phagocytosis of senescent PMN, while protecting
MNC (responsible for their removal) from entering
apoptosis. Ultimately, these events appear to be essen-
tial in the controlled removal of PMN and the resolu-
tion of acute inflammation (43–45).
Although the controlled recruitment and removal
of leukocytes is pivotal to effective host defense and
the resolution of inflammation, their maintenance at
sites of injury or infection contributes directly to dis-
ease pathogenesis (46). The current data suggest that
interplay between IFN-γ and IL-6/sIL-6R signaling
contributes to the rapid recruitment and timely
removal of PMN from sites of acute inflammation. In
the context of host defense, these data provide a
rationale at the level of leukocyte trafficking for the
obligate role of IFN-γ in controlling bacterial and viral
infection and resolution of acute inflammation (1, 2,
4). In more chronic conditions such as hepatitis,
inflammatory bowel disease, and arthritis, however,
characterized by activated T cell infiltration, the bal-
ance of STAT1 and STAT3 signaling (presumably
controlled by local IL-6 and IFN-γ levels) contributes
directly to disease progression (41, 42, 47). Taken
together, these data emphasize that irrespective of dis-
ease context, the regulated or deregulated interplay
between the effects of IL-6 and IFN-γ are central to the
control of leukocyte trafficking in inflammatory dis-
ease. Consequently, understanding the contribution
of IFN-γ and IL-6/sIL-6R signaling to leukocyte traf-
ficking in both acute and chronic inflammatory
states is essential if appropriate therapeutic strategies
aimed at more effective host defense, or reducing the
detrimental consequences of unresolved chronic
inflammation, are to be achieved.
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